SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-16-713550
Filing Date
2016-09-19
Accepted
2016-09-19 16:51:56
Documents
2
Group Members
AMIR NASHATBRIAN CHEEBRYCE YOUNGRENDAVID BARRETTJONATHAN A. FLINTKEVIN BITTERMANPOLARIS VENTURE FOUNDERS FUND VI, L.P.POLARIS VENTURE MANAGEMENT CO. VI, L.L.C.TERRANCE G. MCGUIRE

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d248563dsc13da.htm SC 13D/A 160215
2 EX-99.A d248563dex99a.htm EX-99.A 10760
  Complete submission text file 0001193125-16-713550.txt   172826
Mailing Address 1000 WINTER STREET, SUITE 3350 WALTHAM MA 02451
Business Address 1000 WINTER STREET, SUITE 3350 WALTHAM MA 02451 781-290-0770
Polaris Venture Partners VI, L.P. (Filed by) CIK: 0001493463 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 300 THIRD STREET FIRST FLOOR CAMBRIDGE MA 02142
Business Address 300 THIRD STREET FIRST FLOOR CAMBRIDGE MA 02142 617-401-9000
Editas Medicine, Inc. (Subject) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89319 | Film No.: 161892214
SIC: 2836 Biological Products, (No Diagnostic Substances)